Chrissy Bolton, MD, MBBS
University of Oxford
Oxford, United Kingdom
Disclosure information not submitted.
Scott Canna, MD
Children's Hospital of Philadelphia
Philadelphia, PA, United States
Disclosure(s): Apollo Therapeutics: Consultant (Ongoing); Novartis: Site PI for industry-sponsored trial (Ongoing); PracticePoint CME: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Simcha Therapeutics: Consultant (Terminated, December 31, 2022); Sobi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, May 31, 2023)
Christopher Mahony, PhD, BSc
University of Birmingham
Birmingham, United Kingdom
Disclosure information not submitted.
Michael Ombrello, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
North Bethesda, MD, United States
Disclosure information not submitted.
Gabrielle Rabadam, PhD
University of California San Francisco
San Francisco, CA, United States
Disclosure information not submitted.
Kathryn Torok, MD
University of Pittsburgh
Pittsburgh, PA, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Abstract oral session.
Non-CME
Presenting Author: Gabrielle Rabadam, PhD – University of California San Francisco
Presenting Author: Chrissy Bolton, MD, MBBS – University of Oxford
Presenting Author: Christopher Mahony, PhD, BSc – University of Birmingham
Presenting Author: Michael Ombrello, MD – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
Presenting Author: Kathryn Torok, MD – University of Pittsburgh
Presenting Author: Scott Canna, MD – Children's Hospital of Philadelphia